We read with interest the recent article by Bräunlich et al entitled 'Nasal high-flow versus non-invasive ventilation in patients with chronic hypercapnic COPD' recently published in the International Journal of COPD. 1 It covers an important topic, as this is the first study comparing non-invasive ventilation (NIV) and nasal high flow (NHF) therapy in stable hypercapnic COPD patients.
with regard to optimal nHFT titration is needed to show whether NHF is a (superior) alternative to NIV in reducing hypercapnia and, more importantly, in achieving improvement in patient-related outcomes.
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